Literature DB >> 8910104

Cardiac autonomic nerve function and insulin sensitivity in obese subjects.

W O Richter1, H C Geiss, S Aleksic, P Schwandt.   

Abstract

OBJECTIVE: To investigate whether obesity influences cardiac autonomic nerve function.
DESIGN: Comparing two groups of subjects with different degrees of obesity to normal weight controls.
SUBJECTS: 19 healthy controls (mean age 33 y, BMI 21.7 +/- 0.2 kg/m2) and 17 obese non-diabetic subjects (mean age 39 y, BMI 33.7 +/- 1.8 kg/m2). MEASUREMENTS: Insulin sensitivity was calculated by an oral glucose tolerance test. Autonomic nerve function was evaluated by analysing the variation of the heart frequency at rest (coefficient variation of R-R intervals, REST 1), during deep respiration, at a Valsalva maneuver (longest/shortest R-R interval during inspiration hold) and by the Ewing test (ratio between the 30th and 15th R-R interval after reaching up-right position).
RESULTS: The obese showed a lower insulin sensitivity than healthy controls (3.09 vs 4.60 mg x l2/mmol x mU x min, P < 0.001). Their variation in heart frequency was reduced (REST 1: 1.95 vs 2.9, P < 0.01, Valsalva: 1.30 vs 1.52 and Ewing test: 1.03 vs 1.14, P < 0.05). However, patients with moderate (BMI 31.7 kg/m2) or severe obesity (39.0 kg/m2) with identical insulin sensitivity had no significant difference in autonomic nerve function. Except for the Ewing test all measured parameters for the evaluation of cardiac autonomic nerve function correlated with the degree of diminished insulin sensitivity (REST 1: r = 0.475, P < 0.001).
CONCLUSION: Moderate obesity with significantly decreased insulin sensitivity is associated with impaired cardiac autonomic nerve function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8910104

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  6 in total

Review 1.  Vagus nerve cholinergic circuitry to the liver and the gastrointestinal tract in the neuroimmune communicatome.

Authors:  Christine N Metz; Valentin A Pavlov
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-07-12       Impact factor: 4.052

2.  Galantamine alleviates inflammation and other obesity-associated complications in high-fat diet-fed mice.

Authors:  Sanjaya K Satapathy; Mahendar Ochani; Meghan Dancho; Laqueta K Hudson; Mauricio Rosas-Ballina; Sergio I Valdes-Ferrer; Peder S Olofsson; Yael Tobi Harris; Jesse Roth; Sangeeta Chavan; Kevin J Tracey; Valentin A Pavlov
Journal:  Mol Med       Date:  2011-07-01       Impact factor: 6.354

Review 3.  The vagus nerve and the inflammatory reflex--linking immunity and metabolism.

Authors:  Valentin A Pavlov; Kevin J Tracey
Journal:  Nat Rev Endocrinol       Date:  2012-12       Impact factor: 43.330

Review 4.  Neural circuitry and immunity.

Authors:  Valentin A Pavlov; Kevin J Tracey
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

5.  Obesity Prolongs the Inflammatory Response in Mice After Severe Trauma and Attenuates the Splenic Response to the Inflammatory Reflex.

Authors:  Fabian Gärtner; Adrian Gihring; Aileen Roth; Joachim Bischof; Pengfei Xu; Leonard Elad; Martin Wabitsch; Timo Burster; Uwe Knippschild
Journal:  Front Immunol       Date:  2021-11-15       Impact factor: 7.561

6.  Antidiabetic Effect of Galantamine: Novel Effect for a Known Centrally Acting Drug.

Authors:  Mennatallah A Ali; Hanan S El-Abhar; Maher A Kamel; Ahmed S Attia
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.